Not all Pseudomonas aeruginosa are equal: strains from industrial sources possess uniquely large multireplicon genomes.


Journal

Microbial genomics
ISSN: 2057-5858
Titre abrégé: Microb Genom
Pays: England
ID NLM: 101671820

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 7 6 2019
medline: 30 1 2020
entrez: 7 6 2019
Statut: ppublish

Résumé

Pseudomonas aeruginosa is a highly versatile, antibiotic-resistant Gram-negative bacterium known for causing opportunistic infections and contamination of industrial products. Despite extensive genomic analysis of clinical P. aeruginosa strains, no genomes exist for preservative-tolerant industrial strains. A unique collection of 69 industrial isolates was assembled and compared to clinical and environmental strains; 16 genetically distinct industrial strains were subjected to array tube genotyping, multilocus sequence typing and whole-genome sequencing. The industrial strains possessed high preservative tolerance and were dispersed widely across P. aeruginosa as a species, but recurrence of strains from the same lineage within specific industrial products and locations was identified. The industrial P. aeruginosa genomes (mean=7.0 Mb) were significantly larger than those of previously sequenced environmental (mean=6.5 Mb; n=19) and clinical (mean=6.6 Mb; n=66) strains. Complete sequencing of the P. aeruginosa industrial strain RW109, which encoded the largest genome (7.75 Mb), revealed a multireplicon structure including a megaplasmid (555 265 bp) and large plasmid (151 612 bp). The RW109 megaplasmid represented an emerging plasmid family conserved in seven industrial and two clinical P. aeruginosa strains, and associated with extremely stress-resilient phenotypes, including antimicrobial resistance and solvent tolerance. Here, by defining the detailed phylogenomics of P. aeruginosa industrial strains, we show that they uniquely possess multireplicon, megaplasmid-bearing genomes, and significantly greater genomic content worthy of further study.

Identifiants

pubmed: 31170060
doi: 10.1099/mgen.0.000276
pmc: PMC6700666
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/L015080/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M009122/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L502078/1/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/F016557/1
Pays : United Kingdom

Références

Appl Environ Microbiol. 2011 Jul;77(13):4527-38
pubmed: 21602386
Nucleic Acids Res. 2016 Jul 8;44(W1):W242-5
pubmed: 27095192
Methods Mol Biol. 2014;1079:155-70
pubmed: 24170401
PDA J Pharm Sci Technol. 2007 Sep-Oct;61(5):383-99
pubmed: 18047177
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
BMC Vet Res. 2015 Jan 21;11:9
pubmed: 25604773
Pathog Dis. 2014 Jun;71(1):20-5
pubmed: 24167005
Antimicrob Agents Chemother. 2013 Jul;57(7):3348-57
pubmed: 23650175
Microb Genom. 2016 Sep 20;2(9):e000086
pubmed: 28785418
J Microbiol Methods. 2014 Apr;99:8-14
pubmed: 24472675
J Biotechnol. 2015 Apr 20;200:17-8
pubmed: 25746905
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
PLoS One. 2015 May 11;10(5):e0126468
pubmed: 25961859
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Nucleic Acids Res. 2017 Jan 9;45(1):67-80
pubmed: 27899609
Nucleic Acids Res. 2009 Jan;37(Database issue):D483-8
pubmed: 18978025
Nucleic Acids Res. 2017 Jul 3;45(W1):W30-W35
pubmed: 28472413
J Antimicrob Chemother. 2009 Mar;63(3):502-10
pubmed: 19153076
J Bacteriol. 2004 Mar;186(5):1518-30
pubmed: 14973027
Oncotarget. 2017 Jul 22;8(40):68439-68447
pubmed: 28978128
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W182-5
pubmed: 17526522
J Antimicrob Chemother. 2017 Aug 1;72(8):2225-2229
pubmed: 28505370
PLoS One. 2010 Oct 19;5(10):e13482
pubmed: 20976062
Genome Announc. 2016 Dec 8;4(6):
pubmed: 27932659
Antimicrob Agents Chemother. 2013 Jul;57(7):2972-80
pubmed: 23587949
J Clin Microbiol. 2004 Dec;42(12):5644-9
pubmed: 15583294
Microbiology (Reading). 2012 Apr;158(Pt 4):1005-1015
pubmed: 22282518
Antimicrob Agents Chemother. 2013 Sep;57(9):4381-6
pubmed: 23817379
J Bacteriol. 2008 Apr;190(8):2804-13
pubmed: 18083816
Nat Rev Microbiol. 2005 Feb;3(2):144-56
pubmed: 15643431
Clin Microbiol Rev. 2003 Apr;16(2):189-208
pubmed: 12692093
Genome Biol. 2006;7(10):R90
pubmed: 17038190
J Vis Exp. 2011 Jan 30;(47):
pubmed: 21307833
Nat Commun. 2020 Mar 13;11(1):1370
pubmed: 32170080
Am J Infect Control. 1995 Dec;23(6):396-8
pubmed: 8821117
Arch Microbiol. 2011 May;193(5):313-21
pubmed: 21374058
J Clin Microbiol. 1996 May;34(5):1129-35
pubmed: 8727889
Expert Rev Anti Infect Ther. 2013 Mar;11(3):297-308
pubmed: 23458769
Environ Microbiol Rep. 2015 Dec;7(6):955-60
pubmed: 26419222
Microbiologyopen. 2013 Dec;2(6):1010-23
pubmed: 24214409
Nucleic Acids Res. 2016 Jul 8;44(W1):W16-21
pubmed: 27141966
Bioinformatics. 2005 Feb 15;21(4):537-9
pubmed: 15479716
Genome Res. 2009 Jan;19(1):12-23
pubmed: 19047519
Proc Natl Acad Sci U S A. 2007 May 8;104(19):8101-6
pubmed: 17468398
Microbiology (Reading). 2015 Oct;161(10):1961-1977
pubmed: 26253522
J Am Chem Soc. 2017 Jun 14;139(23):7974-7981
pubmed: 28528545
PLoS One. 2010 Jan 22;5(1):e8842
pubmed: 20107499
Nature. 2000 Aug 31;406(6799):959-64
pubmed: 10984043
J Clin Microbiol. 2011 Mar;49(3):993-1003
pubmed: 21227987
Contact Dermatitis. 2009 Feb;60(2):70-8
pubmed: 19207376
Environ Microbiol. 2012 Aug;14(8):1952-67
pubmed: 22390474
Nucleic Acids Res. 2000 Jan 1;28(1):33-6
pubmed: 10592175
Antimicrob Agents Chemother. 2013 Aug;57(8):3775-82
pubmed: 23716048
Br Med J (Clin Res Ed). 1984 Dec 8;289(6458):1584
pubmed: 6439331
PLoS One. 2009 Nov 13;4(11):e7740
pubmed: 19936230
Clin Microbiol Rev. 2010 Apr;23(2):299-323
pubmed: 20375354
PLoS One. 2012;7(11):e50731
pubmed: 23209821
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Mol Biol Evol. 2009 Jul;26(7):1641-50
pubmed: 19377059
Brief Bioinform. 2019 Jul 19;20(4):1576-1582
pubmed: 28968859
Arch Ophthalmol. 1979 Sep;97(9):1640-1
pubmed: 112953
Front Microbiol. 2015 Sep 29;6:1036
pubmed: 26483767

Auteurs

Rebecca Weiser (R)

Microbiomes, Microbes and Informatics Group, Organisms and Environment Division, Cardiff School of Biosciences, Cardiff University, Cardiff, Wales, UK.

Angharad E Green (AE)

Microbiomes, Microbes and Informatics Group, Organisms and Environment Division, Cardiff School of Biosciences, Cardiff University, Cardiff, Wales, UK.
University of Liverpool, Institute of Infection and Global Health, Liverpool, UK.

Matthew J Bull (MJ)

Microbiomes, Microbes and Informatics Group, Organisms and Environment Division, Cardiff School of Biosciences, Cardiff University, Cardiff, Wales, UK.

Edward Cunningham-Oakes (E)

Microbiomes, Microbes and Informatics Group, Organisms and Environment Division, Cardiff School of Biosciences, Cardiff University, Cardiff, Wales, UK.

Keith A Jolley (KA)

Department of Zoology, The Tinbergen Building, University of Oxford, Oxford, UK.

Martin C J Maiden (MCJ)

Department of Zoology, The Tinbergen Building, University of Oxford, Oxford, UK.

Amanda J Hall (AJ)

University of Liverpool, Institute of Infection and Global Health, Liverpool, UK.

Craig Winstanley (C)

University of Liverpool, Institute of Infection and Global Health, Liverpool, UK.

Andrew J Weightman (AJ)

Microbiomes, Microbes and Informatics Group, Organisms and Environment Division, Cardiff School of Biosciences, Cardiff University, Cardiff, Wales, UK.

Denise Donoghue (D)

Unilever Research and Development, Port Sunlight, Wirral, UK.

Alejandro Amezquita (A)

Unilever Research and Development, Safety and Environmental Assurance Centre, Colworth House, Sharnbrook, Bedford, UK.

Thomas R Connor (TR)

Microbiomes, Microbes and Informatics Group, Organisms and Environment Division, Cardiff School of Biosciences, Cardiff University, Cardiff, Wales, UK.

Eshwar Mahenthiralingam (E)

Microbiomes, Microbes and Informatics Group, Organisms and Environment Division, Cardiff School of Biosciences, Cardiff University, Cardiff, Wales, UK.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH